Survival of children with bone sarcoma in Europe since 1978: results from the EUROCARE study

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
C A StillerEUROCARE Working Group

Abstract

Malignant bone tumours in children are rare, accounting for approximately 5% of all childhood cancers in European countries. In the EUROCARE childhood cancer study, there were 1785 registrations from 16 countries for bone cancers in patients aged 0--14 years during 1978--1989. Of this total, almost three-quarters were contributed by childhood cancer registries in Germany and the UK. Estimated 5-year survival rates were 52% for osteosarcoma and 50% for Ewing's sarcoma over the entire study period and 60% for both diagnostic groups in 1985--1989. For osteosarcoma, survival rates increased substantially until about 1985, but then showed no further improvement. For Ewing's sarcoma, there was a steady increase throughout the study period. Improvements in survival which had previously been reported from individual countries and in clinical series are confirmed as having taken place throughout much of Europe on a population basis.

References

Jan 1, 1995·Japanese Journal of Cancer Research : Gann·W AjikiI Fujimoto
Dec 11, 1995·International Journal of Cancer. Journal International Du Cancer·G GilesH Farrugia
Jun 1, 1997·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A W CraftD Pearson
Apr 20, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·C MagnaniC Stiller
Apr 20, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·F LeviF Lucchini

❮ Previous
Next ❯

Citations

Oct 13, 2006·Journal of Cancer Research and Clinical Oncology·Crispin R DassPeter F M Choong
Sep 20, 2005·Clinical & Experimental Metastasis·Hue H LuuTong-Chuan He
Apr 14, 2009·Clinical & Experimental Metastasis·Yuxi SuHue H Luu
Dec 4, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·F LeviC La Vecchia
Apr 20, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·F LeviF Lucchini
Apr 20, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·B TerraciniA Zappone
Jul 10, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S BielackUNKNOWN ESMO Guidelines Working Group
Jun 29, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P C W HogendoornD Vanel
Oct 15, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J Ritter, S S Bielack
Nov 20, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·UNKNOWN ESMO / European Sarcoma Network Working Group
Jun 25, 2008·International Urology and Nephrology·Amr Al-NajarChristof van der Horst
Sep 12, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·UNKNOWN ESMO/European Sarcoma Network Working Group
Feb 25, 2009·Expert Opinion on Investigational Drugs·Rachael WindsorJeremy Whelan
Jun 23, 2015·Molecular Medicine Reports·Lu SunBing Yan
Feb 14, 2003·Mayo Clinic Proceedings·Peter M Anderson
Jan 22, 2011·Sarcoma·Robert GrimerJeremy Whelan
Apr 3, 2008·The Journal of Pharmacy and Pharmacology·Crispin R Dass, Peter F M Choong
Aug 22, 2006·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·C A StillerE Steliarova-Foucher
May 28, 2004·Expert Opinion on Pharmacotherapy·Stefan S BielackHeribert Jürgens
Jun 28, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Jakob K AnningaR Maarten Egeler
Oct 20, 2012·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·C A StillerUNKNOWN RARECARE Working Group
Jun 6, 2017·Journal of Pediatric Hematology/oncology·Pierre-Aurélien BeuriatKevin Beccaria
Apr 26, 2012·Rare Tumors·Mahdi AghiliMahkameh Zare
Sep 8, 2016·Journal of Pediatric Orthopedics·Minna LaitinenRobert Grimer
Apr 30, 2013·Asian Pacific Journal of Cancer Prevention : APJCP·Worawut ChoeyprasertSomjai Sittipreechacharn
Jan 13, 2006·The Oncologist·Michelle Scurr, Ian Judson
Apr 6, 2018·International Journal of Molecular Medicine·Hao ShenZhanchao Wang
Feb 9, 2019·Medicine·Zhenguo LuoChunsheng Wang
Jan 1, 2015·Journal of Orthopaedic Surgery·Kentaro IgarashiHiroyuki Tsuchiya
Dec 15, 2017·Calcified Tissue International·Hannah K BrownDominique Heymann
Mar 7, 2021·Cells·Lorena LanduzziKatia Scotlandi
Jul 6, 2020·Bone·Marie-Francoise HeymannDominique Heymann
Jul 16, 2021·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Chia-Hsuan ChouShun-Fa Yang
Oct 23, 2021·Biochemical Pharmacology·Mathilde MullardFranck Verrecchia

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Leo KagerCooperative German-Austrian-Swiss Osteosarcoma Study Group
European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
J S Whelan
Journal of Cancer Research and Clinical Oncology
Jonathan C M ClarkPeter F M Choong
Radiographics : a Review Publication of the Radiological Society of North America, Inc
M D MurpheyM J Kransdorf
© 2021 Meta ULC. All rights reserved